Analysed MERCK KGAA (MKGAF:OTCMKTS) News Sources
Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson's Disease
12-08-2026
yahoo.com
Remepy secures $36m funding for hybrid drug pipeline expansion
13-08-2026
pharmaceutical-technology.com
Sandoz targets industry patent void with $322m Henlius deal
17-08-2026
pharmaceutical-technology.com
IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players
08-09-2026
yahoo.com
Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others
08-09-2026
yahoo.com
TwoStep Therapeutics raises $62.5m in funding to advance TS-104
10-09-2026
pharmaceutical-technology.com
Single-Use Bioreactors Market by Product, Type, Cell Type, Molecule, Process Mode, Application, Competition, Region - Global Forecast to 2031
15-09-2026
yahoo.com
What is the current price of MERCK KGAA (MKGAF:OTCMKTS)?
The current price of MERCK KGAA (MKGAF:OTCMKTS) is $151.92.
MERCK KGAA (MKGAF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MERCK KGAA (MKGAF:OTCMKTS) since the previous trading day is $-5.44.
MERCK KGAA (MKGAF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MERCK KGAA (MKGAF:OTCMKTS) since the previous trading day is -3.457%.
What is the most recent average sentiment score for MERCK KGAA (MKGAF:OTCMKTS)?
The most recent average sentiment score for MERCK KGAA (MKGAF:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for MERCK KGAA (MKGAF:OTCMKTS)?
The most recent sentiment for MERCK KGAA (MKGAF:OTCMKTS) is .
SEC-8K** Filing Available For MERCK KGAA (MKGAF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.